• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环肿瘤细胞可预测转移性前列腺癌患者的生存情况。

Circulating tumor cells predict survival in patients with metastatic prostate cancer.

作者信息

Moreno Jose G, Miller M Craig, Gross Steve, Allard W Jeffrey, Gomella Leonard G, Terstappen Leon W M M

机构信息

Department of Urology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

出版信息

Urology. 2005 Apr;65(4):713-8. doi: 10.1016/j.urology.2004.11.006.

DOI:10.1016/j.urology.2004.11.006
PMID:15833514
Abstract

OBJECTIVES

To determine whether circulating tumor cells (CTCs) predict for survival in patients with metastatic prostate cancer (PCa) and to compare its prognostic abilities with other clinical factors.

METHODS

Blood samples from 37 patients with metastatic PCa were analyzed for CTCs. CTCs were enriched from 7.5 mL blood using magnetic nanoparticles targeting the epithelial cell adhesion molecule and then fluorescently labeled. The samples were analyzed by multiparameter flow cytometry, and events with appropriate light scatter properties that were nucleic acid dye positive, cytokeratin positive, and CD45 negative were defined as CTCs.

RESULTS

The number of CTCs found ranged from 0 to 8586 per 7.5 mL (mean 530 +/- 1887, median 5). A threshold of 5 or more CTCs per 7.5 mL of blood was used to evaluate the ability of CTCs to predict for overall survival. Of the 37 patients, 23 (62%) had 5 or more CTCs, with a median overall survival of 0.70 year compared with more than 4 years for those patients with fewer than 5 CTCs (log-rank P = 0.002, Cox hazards ratio 7.4). In the subset of 26 patients with hormone-refractory PCa, the presence of CTCs was the most significant parameter predictive of survival in univariate and multivariate analyses.

CONCLUSIONS

In this pilot study, the presence of 5 or more CTCs in 7.5 mL blood was associated with poor overall survival in patients with metastatic PCa.

摘要

目的

确定循环肿瘤细胞(CTC)是否可预测转移性前列腺癌(PCa)患者的生存情况,并将其预后能力与其他临床因素进行比较。

方法

对37例转移性PCa患者的血样进行CTC分析。使用靶向上皮细胞粘附分子的磁性纳米颗粒从7.5 mL血液中富集CTC,然后进行荧光标记。通过多参数流式细胞术分析样本,将具有适当光散射特性、核酸染料阳性、细胞角蛋白阳性且CD45阴性的事件定义为CTC。

结果

每7.5 mL血液中发现的CTC数量范围为0至8586个(平均530±1887个,中位数5个)。以每7.5 mL血液中5个或更多CTC为阈值来评估CTC预测总生存的能力。在37例患者中,23例(62%)有5个或更多CTC,其中位总生存期为0.70年,而CTC少于5个的患者中位总生存期超过4年(对数秩检验P = 0.002,Cox风险比7.4)。在26例激素难治性PCa患者亚组中,在单变量和多变量分析中,CTC的存在是生存的最显著预测参数。

结论

在这项初步研究中,7.5 mL血液中存在5个或更多CTC与转移性PCa患者的总生存较差相关。

相似文献

1
Circulating tumor cells predict survival in patients with metastatic prostate cancer.循环肿瘤细胞可预测转移性前列腺癌患者的生存情况。
Urology. 2005 Apr;65(4):713-8. doi: 10.1016/j.urology.2004.11.006.
2
Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.循环肿瘤细胞的免疫磁珠定量分析作为激素初治转移性前列腺癌患者雄激素剥夺反应性的预后因素
J Urol. 2008 Oct;180(4):1342-7. doi: 10.1016/j.juro.2008.06.021. Epub 2008 Aug 15.
3
Prognostic significance of circulating tumor cells in patients with hormone refractory prostate cancer.激素难治性前列腺癌患者循环肿瘤细胞的预后意义
J Urol. 2009 Mar;181(3):1091-7. doi: 10.1016/j.juro.2008.11.015. Epub 2009 Jan 16.
4
Detection of circulating tumor cells in breast cancer patients utilizing multiparameter flow cytometry and assessment of the prognosis of patients in different CTCs levels.利用多参数流式细胞术检测乳腺癌患者循环肿瘤细胞,并评估不同 CTCs 水平患者的预后。
Cytometry A. 2010 Mar;77(3):213-9. doi: 10.1002/cyto.a.20838.
5
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.转移性结直肠癌患者循环肿瘤细胞与肿瘤反应、无进展生存期和总生存期的关系。
J Clin Oncol. 2008 Jul 1;26(19):3213-21. doi: 10.1200/JCO.2007.15.8923.
6
Association of circulating tumor cells with tumor-related methylated DNA in patients with hormone-refractory prostate cancer.循环肿瘤细胞与激素难治性前列腺癌患者肿瘤相关甲基化 DNA 的关系。
Int J Urol. 2010 May;17(5):466-75. doi: 10.1111/j.1442-2042.2010.02502.x. Epub 2010 Mar 10.
7
Evaluation and significance of circulating epithelial cells in patients with hormone-refractory prostate cancer.激素难治性前列腺癌患者循环上皮细胞的评估及意义
BJU Int. 2007 Mar;99(3):519-24. doi: 10.1111/j.1464-410X.2007.06659.x.
8
Apoptosis of circulating tumor cells in prostate cancer patients.前列腺癌患者循环肿瘤细胞的凋亡
Cytometry A. 2004 Nov;62(1):46-53. doi: 10.1002/cyto.a.20073.
9
Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.循环肿瘤细胞和[18F]氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在转移性乳腺癌预后预测中的应用
J Clin Oncol. 2009 Jul 10;27(20):3303-11. doi: 10.1200/JCO.2008.19.4423. Epub 2009 May 18.
10
Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer.循环肿瘤细胞:新诊断转移性乳腺癌的一种新型预后因素。
J Clin Oncol. 2005 Mar 1;23(7):1420-30. doi: 10.1200/JCO.2005.08.140.

引用本文的文献

1
Prospects for Fluorescence Molecular Liquid Biopsy of Circulating Tumor Cells in Humans.人类循环肿瘤细胞荧光分子液体活检的前景
Front Photon. 2022;3. doi: 10.3389/fphot.2022.910035. Epub 2022 May 8.
2
Dissemination of Circulating Tumor Cells in Breast and Prostate Cancer: Implications for Early Detection.循环肿瘤细胞在乳腺癌和前列腺癌中的传播:对早期检测的影响。
Endocrinology. 2024 Feb 20;165(4). doi: 10.1210/endocr/bqae022.
3
Characterizing Circulating Tumor Cells and Tumor-Derived Extracellular Vesicles in Metastatic Castration-Naive and Castration-Resistant Prostate Cancer Patients.
转移性去势初治和去势抵抗性前列腺癌患者循环肿瘤细胞和肿瘤源性细胞外囊泡的特征分析
Cancers (Basel). 2022 Sep 10;14(18):4404. doi: 10.3390/cancers14184404.
4
Overcoming Obstacles in Liquid Biopsy Developments for Prostate Cancer.克服前列腺癌液体活检发展中的障碍
Onco Targets Ther. 2022 Aug 26;15:897-912. doi: 10.2147/OTT.S285758. eCollection 2022.
5
From Exosomes to Circulating Tumor Cells: Using Microfluidics to Detect High Predictive Cancer Biomarkers.从外泌体到循环肿瘤细胞:利用微流控技术检测高预测性癌症生物标志物。
Adv Exp Med Biol. 2022;1379:369-387. doi: 10.1007/978-3-031-04039-9_15.
6
Signal and measurement considerations for human translation of diffuse in vivo flow cytometry.用于体内扩散流式细胞术的人类翻译的信号和测量注意事项。
J Biomed Opt. 2022 Jun;27(6). doi: 10.1117/1.JBO.27.6.067001.
7
Microfluidic-Based Technologies for CTC Isolation: A Review of 10 Years of Intense Efforts towards Liquid Biopsy.基于微流控技术的循环肿瘤细胞分离:液体活检十年来的努力综述。
Int J Mol Sci. 2022 Feb 10;23(4):1981. doi: 10.3390/ijms23041981.
8
Chromosome compartmentalization alterations in prostate cancer cell lines model disease progression.前列腺癌细胞系中染色体区室化改变模型疾病进展。
J Cell Biol. 2022 Feb 7;221(2). doi: 10.1083/jcb.202104108. Epub 2021 Dec 10.
9
Blood-Derived Biomarkers of Diagnosis, Prognosis and Therapy Response in Prostate Cancer Patients.前列腺癌患者诊断、预后及治疗反应的血液源性生物标志物
J Pers Med. 2021 Apr 13;11(4):296. doi: 10.3390/jpm11040296.
10
Circulating Tumor Cell Genomic Evolution and Hormone Therapy Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer.循环肿瘤细胞基因组进化与转移性去势抵抗性前列腺癌男性患者激素治疗结局的关系。
Mol Cancer Res. 2021 Jun;19(6):1040-1050. doi: 10.1158/1541-7786.MCR-20-0975. Epub 2021 Mar 26.